Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8900
-0.0193 (-2.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.8880
-0.0020 (-0.22%)
After-hours: Dec 5, 2025, 8:00 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $18.53 million as of December 5, 2025. Its market cap has decreased by -1.87% in one year.
Market Cap
18.53M
Enterprise Value
12.96M
1-Year Change
-1.87%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $18.53M, a decrease of -44.50%. That is a compound annual growth rate of -38.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 18.53M | -5.10% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |